Fabien Praz

Seeing differently, treating better: advanced imaging shaping modern structural heart practice

20 May 2026 – From EuroPCR 2026

This session explores the transformative role of advanced imaging, particularly 3D intracardiac echocardiography (ICE), in modern structural heart interventions. It provides practical insights into implementation, highlighting how these tools can enhance workflow efficiency and procedural confidence across transcatheter edge-to-edge repair (TEER), left atrial appendage (LAA) closure,...

Seeing differently, treating better: advanced imaging shaping modern structural heart practice

Beyond visualisation: the value and future of 4D intracardiac echocardiography in tricuspid repair and replacement

20 May 2026 – From EuroPCR 2026

Explore the transformative role of 4D intracardiac echocardiography in guiding tricuspid edge-to-edge repair (TEER) and valve replacement for tricuspid regurgitation. This session highlights how real-time, high-resolution imaging enhances procedural efficiency and safety, reducing reliance on general anesthesia and shortening procedure times compared to traditional imaging modalities.

Tricuspid interventions: find the best candidate

20 May 2026 – From EuroPCR 2026

This session reviews the phenotypes of tricuspid regurgitation and their diagnostic pathways, emphasizing standardized and pragmatic diagnostic steps. It also addresses criteria for identifying optimal timing and candidates for tricuspid valve interventions.

When less is better - Differentiated therapies to safely achieve TR 0-1+

19 May 2026 – From EuroPCR 2026

Therapeutic goals in tricuspid regurgitation are evolving, with increasing emphasis on achieving near-complete elimination of regurgitation (TR 0–1+) through differentiated transcatheter strategies.

This EuroPCR 2026 session explores how transcatheter edge-to-edge repair (TEER) and transcatheter tricuspid valve replacement (TTVR) can be used in a complementary way to reach...

When less is better - Differentiated therapies to safely achieve TR 0-1+

Outcomes in tricuspid valve intervention

19 May 2026 – From EuroPCR 2026

This session reviews contemporary clinical outcomes of tricuspid valve interventions. Topics include interim results from the Cardiovalve replacement system trial, the impact of atrial fibrillation on tricuspid TEER, residual regurgitation implications, afterload mismatch post-intervention, and long-term bioprosthetic valve durability.

From Guidelines to patients’ lives: how to apply and connect the community

17 Mar 2026

Watch this replay with M. Swaans, P. Lurz, M. Cikes and F. Praz to learn how to differentiate ventricular versus atrial secondary mitral regurgitation phenotypes and much more!

How are the 2025 ESC EACTS valvular guidelines going to impact my TAVI programme?

17 Dec 2025 – From PCR London Valves 2025

Bernard Prendergast and Fabien Praz discuss updates from the new ESC/EACTS guidelines on aortic stenosis. Key changes include expanding TAVI to patients aged 70 and older, supporting early intervention in asymptomatic patients, and providing guidance for bicuspid aortic valves. These updates emphasise shared decision-making, careful patient...

How are the 2025 ESC EACTS valvular guidelines going to impact my TAVI programme

Pills and pumps: targeting heart failure before and after surgical and transcatheter valve interventions

18 Nov 2025 – From PCR London Valves 2025

This session examines the integrated role of heart failure therapies in the peri- and post-procedural management of patients undergoing surgical and transcatheter valve interventions. It reviews current and emerging clinical trial data, discusses identifying high-risk patients, and explores advanced modalities such as cardiac resynchronization and circulatory...

Pills and pumps: targeting heart failure before and after surgical and transcatheter valve interventions

How to manage complications of tricuspid interventions

18 Nov 2025 – From PCR London Valves 2025

This session focuses on the risks and management of complications arising from tricuspid valve repair and replacement procedures. Participants will learn preventive strategies during transcatheter interventions and become familiar with bailout techniques essential for resolving procedural complications effectively and safely.

How to manage complications of tricuspid interventions

Learning from lived experience and contemporary evidence: shaping the treatment of women with heart valve disease

17 Nov 2025 – From PCR London Valves 2025

This session provides an in-depth exploration of the lived experiences of women with valvular heart disease, emphasizing the unique challenges in detection, diagnosis, treatment, and follow-up. It integrates contemporary evidence and the forthcoming 2025 ESC/EACTS guidelines to offer practice-ready strategies tailored to the management of valvular...

What are the key considerations when managing combined mitral and tricuspid regurgitation?

17 Feb 2026 – From PCR London Valves 2025

Fabien Praz and Neil Fam talk about the management of patients with combined mitral and tricuspid regurgitation, who are often elderly with heart failure and multiple comorbidities. Careful assessment—including echocardiography, hemodynamics, and sometimes CT—is crucial to identify the dominant lesion. Surgery is preferred if feasible, but...

What are the key considerations when managing combined mitral and tricuspid regurgitation?

How are the new ESC/EACTS valvular guidelines going to impact my tricuspid programme?

17 Nov 2025 – From PCR London Valves 2025

While the PCR London Valves 2025 Course is underway, Francesco Maisano and Fabien Praz discuss how the latest ESC/EACTS valvular guidelines affect clinical practice. What’s changing in surgery? How do repair and replacement strategies differ under the new recommendations, and what’s the impact on transcatheter interventions?...

How are the 2025 ESC/EACTS valvular guidelines going to impact my tricuspid programme?

ENCIRCLE 1-year outcomes: Shaping the future of MR treatment with the SAPIEN M3 system

18 Nov 2025 – From PCR London Valves 2025

Fabien Praz talks with Mayra Guerrero and Henryk Dreger about the ENCIRCLE trial on the Sapien M3 transcatheter mitral valve, which shows strong safety, durable MR reduction, and improved symptoms, quality of life, and LV remodelling. High-quality CT and echo are essential for #TMVR, which is...

ENCIRCLE 1-year outcomes: Shaping the future of MR treatment with the SAPIEN M3 system

Focus on the right ventricle: patient selection and clinical outcomes after tricuspid valve intervention

16 Nov 2025 – From PCR London Valves 2025

Focused on the often-overlooked right ventricle, this session elucidates methods for accurate assessment of right ventricular function prior to transcatheter tricuspid valve interventions. It explores the role of right heart catheterisation in patient selection and timing, and evaluates long-term remodeling patterns post-procedure, providing critical insights for...

Focus on the right ventricle: patient selection and clinical outcomes after tricuspid valve intervention

Transcatheter tricuspid valve replacement: who to treat and how to implement into my practice

12 Nov 2025

In this on-demand webinar, F. Praz, P. Lurz, M. Adam, and T. Patterson explore TTVR, sharing key insights and the latest clinical evidence supporting TTVR.

What’s new in the 2025 guidance on valvular heart disease - ESC Congress 2025

05 Sep 2025

In this interview, Alex Sticchi speaks with Fabien Praz and Michael Borger, co-chairs of the 2025 ESC/EACTS Valvular Guidelines Task Force. They discuss the major updates, including the central role of multimodality imaging, the lowered age threshold for TAVI, the distinction between atrial and ventricular secondary...

What’s new in the 2025 guidance on valvular heart disease - ESC Congress 2025

The PCR Textbook

08 Jul 2025

The PCR Textbook covers the length and breadth of percutaneous cardiovascular interventional practice, in particular diagnostic and therapeutic areas.

Learn the latest from the PCR Tricuspid Focus Group!

Launch the video to hear Marianna Adamo and Marta Sitges share how they and Julien Dreyfus strengthened the Leadership team at the end of last year, bringing welcome support to founders Francesco Maisano and Fabien Praz.

They explain their individual roles among the PCR Tricuspid Focus Group;...

What did we learn from my TAVI complications?

22 May 2025 – From EuroPCR 2025

Review critical lessons from TAVI complications, focusing on early identification and management of access site issues and acute coronary obstruction. Learn effective preventive actions and procedural strategies to minimize severe TAVI-related complications through detailed case discussions.

What did we learn from my TAVI complications?

Electrosurgical techniques in transcatheter mitral valve replacement

22 May 2025 – From EuroPCR 2025

Delve into electrosurgical techniques in transcatheter mitral valve replacement. This session covers advanced methods including the tip-to-base lampoon technique, electrosurgical laceration of failed devices, left ventricular outflow tract obstruction management, combined septal ablation and valve-in-valve procedures, and management of severe aortic regurgitation post-laceration.

How to build a tricuspid programme?

20 May 2025 – From EuroPCR 2025

Learn how to build a successful tricuspid valve programme with a focus on patient screening protocols, heart team roles, and post-procedural management. Gain expert perspectives on organizational requirements, referral optimization, multidisciplinary collaboration, and quality assessment for tricuspid interventions.

Pacemaker leads and tricuspid interventions: knowns and unknowns

24 Apr 2025

Watch this webinar with F. Praz, J-C. Deharo, J. Dreyfus and B. Mondésert and learn about the mechanisms and risk of interaction between pacemaker lead and the tricuspid valve, and much more!

Aortic valve disease – Imaging strategies for optimal valve selection and outcomes in TAVI

31 Jan 2025 – From PCR Imaging Valves Madrid 2025

Dive into this in-depth session on aortic valve disease, covering essential imaging insights for selecting the ideal TAVI prosthesis, identifying risk markers for pacemaker implantation, and optimizing outcomes in complex cases. Learn how multi-modality imaging aids in diagnosing and managing bioprosthetic valve dysfunction, including detecting patient-prosthesis...

Imaging strategies for optimal valve selection and outcomes in TAVI

Mastering mitral valve disease: diagnosis, management, and intervention

31 Jan 2025 – From PCR Imaging Valves Madrid 2025

Dive into this comprehensive session on mitral valve disease, covering key aspects of diagnosis, classification, assessment, management, and patient selection for transcatheter intervention. Gain in-depth knowledge through real-world case studies and multidisciplinary team discussions, equipping you with essential skills to optimize patient care.

Mastering mitral valve disease: diagnosis, management, and intervention

Focus on the PCR Tricuspid Focus Group - PCR London Valves 2024

Julien Dreyfus and Fabien Praz discuss the mission of the PCR Tricuspid Focus Group, aimed at consolidating knowledge on tricuspid valve regurgitation. The main goal is to define future directions and establish best practices to ensure optimal patient care.

This interview was filmed at PCR London Valves...